Leader humor across levels.

CEO Executive leadership Humor Leadership Strategic leadership TMT

Journal

Current opinion in psychology
ISSN: 2352-2518
Titre abrégé: Curr Opin Psychol
Pays: Netherlands
ID NLM: 101649136

Informations de publication

Date de publication:
10 2023
Historique:
received: 25 07 2023
revised: 05 08 2023
accepted: 09 08 2023
medline: 9 10 2023
pubmed: 15 9 2023
entrez: 14 9 2023
Statut: ppublish

Résumé

Leaders use humor. This humor has real effects and has been a topic of scholarly interest. We review and interpret this literature though the lens of leader hierarchical level (front-line managers versus senior executives), enumerating intriguing research possibilities and practical implications. We know much more about the humor of front-line leaders than executives, and much more about benefits than risks of leader humor. Not only are the risks and benefits likely to be amplified for executives, but they are qualitatively different due to the differential reach of executive leadership. In terms of enacting humor, the more diverse set of observers and stakeholders for executive leaders versus front-line managers creates additional challenges and a narrower window for successful use of humor.

Identifiants

pubmed: 37708609
pii: S2352-250X(23)00133-1
doi: 10.1016/j.copsyc.2023.101688
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101688

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Cecily D Cooper (CD)

Management Department, University of Miami, United States. Electronic address: cecily@miami.edu.

Nathan Hiller (N)

Department of Global Leadership and Management, Florida International University, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH